Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

Wembanyama Faces Critical Test as Series Hangs in Balance

Published

on

Victor Wembanyama

OKLAHOMA CITY — The Western Conference finals shift back to Paycom Center on Tuesday night for a pivotal Game 5 with the series tied 2-2, as the San Antonio Spurs and Oklahoma City Thunder prepare for what could be a defining moment in both franchises’ seasons.

After the Spurs evened the series with a dominant 103-82 victory in Game 4 on Sunday in San Antonio, the road team has won every game so far. Now, the Thunder return home looking to regain control, while the Spurs aim to steal another victory on the road and move within one win of the NBA Finals.

Victor Wembanyama has been the story of the series. The 22-year-old French phenom delivered his most complete playoff performance yet in Game 4, recording 33 points, eight rebounds, five assists and three blocks. His ability to dominate both ends of the floor has given the Spurs a fighting chance against the top-seeded Thunder, the defending champions.

The Spurs lead the series in several key statistical categories, particularly defensive efficiency and points off turnovers. San Antonio forced 20 turnovers in Game 4 while holding Oklahoma City to just 82 points on 33% shooting. That defensive intensity will be tested again in Game 5 against Shai Gilgeous-Alexander and a Thunder team known for its pace and offensive versatility.

Advertisement

Gilgeous-Alexander, the two-time MVP, has averaged strong numbers throughout the series but has been contained more effectively in recent games. Oklahoma City’s depth and home-court advantage make them dangerous, but injuries and fatigue have started to show as the series reaches this critical juncture.

For the Spurs, maintaining the defensive connections that limited the Thunder in Game 4 will be essential. Coach Mitch Johnson has emphasized discipline and collective effort, particularly in containing Oklahoma City’s transition game and perimeter shooting. The Spurs’ length, anchored by Wembanyama, has disrupted the Thunder’s rhythm, but executing away from home remains the primary challenge.

Wembanyama downplayed individual heroics after Game 4. He stressed team defense and consistency as the keys moving forward. The Spurs have shown resilience throughout the postseason, responding well after losses and maintaining focus in hostile environments.

Oklahoma City enters Game 5 with home-court advantage and the experience of being defending champions. Coach Mark Daigneault’s squad has been remarkably consistent all season, but the Spurs have exposed vulnerabilities, particularly in half-court defense and rebounding when Wembanyama is on the floor.

Advertisement

The Thunder will likely adjust by increasing physicality and trying to draw Wembanyama away from the rim. How they handle the Spurs’ switching defense and secondary scoring from players like Devin Vassell, Stephon Castle and De’Aaron Fox will determine if they can reclaim the series lead.

Game 5 represents a classic playoff chess match. The Thunder need to regain their offensive flow and limit turnovers that plagued them in San Antonio. The Spurs must sustain their defensive intensity on the road while getting enough production from their supporting cast to complement Wembanyama’s dominance.

The series has lived up to expectations as a clash between two young, talented cores. Oklahoma City entered as favorites with superior regular-season record and championship experience, but San Antonio has proven it belongs on the same stage. The back-and-forth nature has showcased the future of the Western Conference.

Injuries have played a subtle but important role. Both teams have managed key absences, and fatigue becomes a bigger factor as the series extends. How each side adapts their rotations and manages energy in Game 5 could prove decisive.

Advertisement

For San Antonio, advancing to the NBA Finals would represent a remarkable achievement in just the third year of the Wembanyama era. For Oklahoma City, a return trip to the Finals would validate their status as a dynasty in the making.

The atmosphere at Paycom Center is expected to be electric. Thunder fans have been vocal and supportive throughout the postseason, and they will look to create a hostile environment that disrupts the Spurs’ rhythm.

Wembanyama’s growth has been the most compelling storyline. In his third NBA season, he has elevated his game on the biggest stage, drawing comparisons to all-time greats for his two-way impact. His ability to guard multiple positions while stretching the floor offensively has created matchup nightmares for Oklahoma City.

The Thunder’s defensive schemes have evolved to meet the challenge, but containing Wembanyama while also accounting for San Antonio’s perimeter threats remains difficult. Gilgeous-Alexander’s ability to create his own shot will be crucial in countering the Spurs’ length.

Advertisement

Both teams have shown championship-level poise at different moments. The Spurs’ response after Game 3 demonstrated mental toughness, while the Thunder’s resilience in earlier rounds highlighted their experience.

As Game 5 approaches, focus turns to adjustments. Small changes in defensive rotations, offensive sets and rebounding battles could swing the outcome. The winner of Game 5 will carry significant momentum into the remainder of the series.

The Western Conference finals have already provided memorable moments, from Wembanyama’s logo buzzer-beater in Game 4 to hard-fought battles in Oklahoma City. Game 5 promises more drama as two of the league’s brightest young cores battle for a chance at the championship.

For basketball fans, the series represents the best of the modern NBA — athleticism, skill, tactical sophistication and emerging superstars. Regardless of the outcome, the Western Conference will emerge stronger from this matchup.

Advertisement

Tuesday night’s game carries championship implications. A Spurs victory would give them a 3-2 lead and put them one win away from the Finals. A Thunder win would restore home-court advantage and put Oklahoma City back in the driver’s seat.

As the teams prepare for what could be the most important game of the season so far, the basketball world will be watching. The series has exceeded expectations, and Game 5 has the potential to be its defining chapter.

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

UPS to invest $48 million in cold facilities amid GLP-1 boom

Published

on

UPS to invest $48 million in cold facilities amid GLP-1 boom

United Parcel Service (UPS) trucks are parked at a UPS drop yard on Oct. 28, 2025 in Vernon, California.

Mario Tama | Getty Images

United Parcel Service is investing $48 million in 27 temperature‑controlled facilities as the industry sees a boom in healthcare logistics, CNBC has learned exclusively.

Advertisement

The facilities, located across the Americas, Europe and Asia, are optimized for moving around shipments that need to be kept at certain temperatures. The company said the investment will help it stay ahead of a boom in medicines and pharmaceuticals — like some GLP-1s — that have to be kept at certain temperatures by improving speed and end-to-end chain of custody.

“Our global cross-dock facilities strengthen our end-to-end cold-chain capabilities to ensure critical treatments are delivered safely and reliably to patients around the world,” said Kate Gutmann, UPS’ president of international, healthcare and supply chain solutions. “This effort – and all of our work in healthcare logistics – extends from a deep understanding that we’re doing more than moving packages.”

The demand for temperature-sensitive biologics is projected to grow at an 8.3% compound annual growth rate through 2033 and reach a market value of roughly $39.1 billion, according to Growth Market Reports. Many new medicines are required to be stored at specific temperatures to maintain efficacy, UPS said, making healthcare logistics more crucial than before.

According to the World Health Organization, up to 50% of global vaccines are wasted every year, with a significant portion of that coming from cold-chain storage issues.

Advertisement

“These investments reflect our commitment to continue to align our leading end-to-end supply chain to protect innovative treatments and diagnostics, supporting better patient outcomes,” UPS Healthcare President John Bolla said in a statement.

UPS’ move comes as the industry overall has seen growing investments in the space, especially with the meteoric rise of GLP-1 drugs. Medicines like Novo Nordisk‘s Wegovy and Ozempic require strict refrigeration and temperature control during transit. A November KFF poll found that 1 in 8 Americans are taking GLP-1s.

UPS CEO Carol Tomé said on the company’s first-quarter earnings call in April that healthcare remains one of the company’s top priorities and biggest areas of growth.

“Our global healthcare portfolio has gained market share every year since 2021,” she said on the call. “And in the first quarter of this year, we generated our first $3 billion healthcare revenue quarter ever, with all three of our segments delivering year-over-year revenue growth.”

Advertisement

Tomé added that UPS is committed to continuing to “lean into that space in a meaningful way.”

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Continue Reading

Business

Summit Therapeutics: High-Volatility, Catalyst-Driven Binary Bet (NASDAQ:SMMT)

Published

on

Summit Therapeutics: High-Volatility, Catalyst-Driven Binary Bet (NASDAQ:SMMT)

This article was written by

I would describe myself as a barbell investor focused on two ends of the risk spectrum: relatively safe, income-generating investments on one side, and high-risk, high upside opportunities—primarily binary healthcare and biotech bets—on the other. Professionally, I work as an R&D researcher in the pharmaceutical industry. Combined with my background in economics and self-training in finance, this provides me with unique perspective when evaluating biotech companies. My research spans multiple dimensions of the sector, including platform technologies, IP and freedom-to-operate considerations, mechanistic feasibility, competitive landscapes, binary clinical trial readouts and corporate financials. As an individual investor, I place significant emphasis on valuation, risk management and capital allocation. On the income-investing side of the portfolio, I actively follow dividend paying stock picks, including preferred shares, REITs, BDCs and option-based income ETFs. The objective is to build a durable stream of cash flow that can support moonshot bets on the other side of the barbell. Through my writing on Seeking Alpha, I aim to share independent, research-driven investment ideas from both ends of this barbell approach. My goal is to combine scientific insight, fundamental analysis and risk management to encourage disciplined trading and develop well-grounded investment thesis.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of SMMT either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Form 4 The York Water Company For: 22 June

Published

on


Form 4 The York Water Company For: 22 June

Continue Reading

Business

The long tail of Trump’s trade agenda

Published

on

The long tail of Trump’s trade agenda

Industry experts say the latest proposals are designed to outlast court challenges, political cycles and administrations. 

Continue Reading

Business

Schwebel Baking set to shut down

Published

on

Schwebel Baking set to shut down

Longtime commercial baker to wind down operations over the summer.

Continue Reading

Business

Occidental Offers A 25% Upside At $70 Oil

Published

on

Occidental Offers A 25% Upside At $70 Oil

Occidental Offers A 25% Upside At $70 Oil

Continue Reading

Business

Amazon Prime Day expected to drive $26.3 billion in online sales

Published

on


Amazon Prime Day expected to drive $26.3 billion in online sales

Continue Reading

Business

Alan Greenspan, architect of the modern American economy, dies aged 100

Published

on

Alan Greenspan, architect of the modern American economy, dies aged 100

As chairman of the Federal Reserve, Alan Greenspan became the world’s most high-profile banker.

Continue Reading

Business

Medical Properties: Strong Recovery Potential (NYSE:MPT)

Published

on

Medical Properties Trust: High Safety Margin

This article was written by

I am interested in a lot of technology and AI stocks like Google, Nvidia, AMD, Tesla and Amazon.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of MPT either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Former Federal Reserve chair Alan Greenspan dies

Published

on

Former Federal Reserve chair Alan Greenspan dies

Alan Greenspan, former chair of the board of the governors of the Federal Reserve System, died on Monday at the age of 100 years old, according to a statement from his wife Andrea Mitchell, NBC News chief Washington correspondent and chief foreign affairs correspondent.

”Alan passed away at our home this morning at the age of 100 from complications of Parkinson’s Disease,” Mitchell said in the statement.

Advertisement

“He was a giant of a man who helped shape the U.S. economy for decades under presidents of both parties, but was always honest in acknowledging his mistakes,” she continued. “To me he was my husband, who shaped my life from our very first date in 1984. “

Alan Greenspan

Alan Greenspan Visits “The Daily Briefing” at Fox News Channel Studios on October 17, 2018 in New York City.  ( Steven Ferdman/Getty Images / Getty Images)

“He had ‘irrational exuberance’ for baseball, the Washington Commanders, tennis, golf and music, especially jazz. He will be remembered for his brilliance and his kindness,” Mitchell noted. “Being his life partner was the joy of my life.”

Fox Business Network’s Edward Lawrence contributed to this report

Advertisement
Continue Reading

Trending

Copyright © 2025